Clearmind MedicineNASDAQ: CMND

Vancouver, Canada, June 28, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announces advancement in its proprietary MEAI- based binge behavior regulator program through the granting of patent approval in Hong Kong by the Hong Kong Patent Office

Vancouver, Canada, June 11, 2024 (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announces advancement in its proprietary MEAI- based alcohol substitute beverage program.

Clearmind Medicine (NASDAQ: CMND ) stock is slipping on Thursday after the psychedelics pharmaceutical company's shares underwent a major rally on Wednesday. The news that sent shares of CMND stock higher yesterday was a meeting with the Food and Drug Administration (FDA).

Shares of Clearmind Medicine (NASDAQ: CMND ) stock, which aims to use psychedelics to treat mental health, jumped overnight. This after it completed a meeting with the Food and Drug Administration (FDA) on its trial of a compound to treat Alcohol Use Disorder.

Clearmind Medicine Inc. (NASDAQ:CMND) is on the move this week after favourable stock market news. The company dedicates its resources to discovering a cure for cocaine addiction.

Following another soft opening on Wall Street, Clearmind Medicine (NASDAQ: CMND ) provided an optimistic contrast thanks to positive trial results. Specifically, the biotechnology firm — which focuses on the discovery and development of novel psychedelic-derived therapeutics — saw encouraging advances regarding its novel treatment targeting cocaine addiction.

Clearmind Medicine (NASDAQ: CMND) stock price was among the best-performing in Wall Street on Thursday. The share jumped by more than 32% and reached a high of $5.37.

Penny stocks frequently stand out as a remarkable sector teeming with potential. With their generally low price points and volatility, these investment vehicles can present both incredible opportunities and significant risks.

Clearmind Medicine (NASDAQ: CMND ) stock is taking off on Wednesday even without any recent news from the psychedelic medicine company. There have been no new press releases that explain why shares of CMND stock are climbing today.